Navigation Links
Jeff Kottkamp Chosen to Lead VR Laboratories
Date:10/27/2011

BONITA SPRINGS, Fla., Oct. 27, 2011 /PRNewswire/ -- VR Laboratories LLC today announced the appointment of Jeff Kottkamp to the position of Chief Executive Officer. Kottkamp will oversee operations at VR Laboratories, leading the company's efforts to manufacture and bring world-class botanical consumer, medicinal food and beverage, and pharmaceutical products to foreign and domestic markets.

(Photo: http://photos.prnewswire.com/prnh/20111027/FL95170 )

"There is no other leader better equipped to introduce VR Laboratories to the global marketplace than Jeff Kottkamp," says Robert Gow, chairman and founder of HerbalScience, which licensed its proprietary technology platform to VR Laboratories. "Jeff's experience in bringing global health care business to Florida during his tenure as lieutenant governor, his legal expertise as a top ranking attorney and his roots in Southwest Florida further strengthen VR Laboratories and its position in a growing and competitive industry."

As Florida's 17th lieutenant governor, Kottkamp was chairman of Space Florida, leading Florida's economic development efforts in aerospace AND working with national bio-tech and life sciences companies as well as NASA and the U.S. Air Force Space Command. Kottkamp also led a delegation of Florida businesses at the MEDICA World Forum for Medicine in Dusseldorf, Germany to grow the bio-tech/life science industry in Florida. Additionally, Kottkamp helped bring one of the world's leading bio-tech/ life sciences organizations, the Max Planck Research Institute, to Florida.

Prior to being elected lieutenant governor, Kottkamp was elected to the Florida House of Representatives where he represented parts of Lee, Charlotte and Sarasota counties during three consecutive terms, from November 2000 through 2006 and served as chairman of the Judiciary Committee and Governmental Operations Committee. Kottkamp is an attorney and has worked with several prominent legal firms in Florida.

"VR Laboratories will bring more than 200 new jobs and an estimated $40 million annually into Lee County's economy," says Kottkamp. "Southwest Florida is my home and to facilitate the growth of this organization and establish its presence in Lee County is truly an honor. This is where we will do business and create jobs. Ultimately, we want to contribute to making Southwest Florida the center of the burgeoning global botanical pharmaceutical market."

VR Laboratories is positioned to be the leading global formulator and producer of FDA-approved botanical pharmaceuticals and medicines and proprietary ingredients for medicinal and functional foods and beverages. Medicinal and functional foods and beverages are the fastest growing segments of the global food market. FDA-approved botanical pharmaceuticals, the newest segment of the global pharmaceutical industry, are estimated to achieve a Combined Annual Growth Rate (CAGR) of 600+ percent. The company utilizes the proprietary HerbalScience technology platform, which has fully developed more than 600 medicinal and functional ingredients. For more information, call 239-597-9878. 


'/>"/>
SOURCE VR Laboratories LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
2. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
3. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
4. Fort Worth Surgeon Chosen as Investigator in Clinical Trial for Weight-Loss Device
5. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
6. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
7. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
8. Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety
9. ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services
10. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
11. CardioMEMS Founder Dr. Jay Yadav Chosen as Health-Care Heroes Finalist by Atlanta Business Chronicle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... -- Global Surgical Drainage Device Market: Overview ... excess liquid and air. The fluid to be drained ... Surgical drains are used in a wide variety of ... surgery, neurosurgery, plastic surgery etc. Common use of surgical ... fluid e.g. blood or pus. Surgical drains are available ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus ... that’s the first in a new class of photodynamic cosmetics (PDC). , Allumera® ... skin, visibly reduce outward signs of aging, and minimize the appearance of pores ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent ... test score performance for the 2015-16 school year across Wisconsin’s public schools, charter ... it highlights important patterns in student test score performance, the report’s limited analyses ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
Breaking Medicine News(10 mins):